Articles from binx health

binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced key findings from a new Massachusetts General Hospital (MGH) study designed to assess the real-world impact of Point of Care (“POC”) testing for Chlamydia trachomatis (“CT”) and Neisseria gonorrhoeae (“NG”) testing in symptomatic patients presenting at a sexual health clinic.

“Global HIV, viral hepatitis epidemics and sexually transmitted infections (STIs) continue to pose significant public health challenges, causing 2.5 million deaths each year,” according to a new WHO report. The report found four curable STIs -- chlamydia, gonorrhea, syphilis and trichomoniasis -- are responsible for more than 1 million infections daily among adults between ages 15 and 49, and binx health is continuing its strategy of expanding access to rapid onsite testing for chlamydia and gonorrhea, which are the most common reportable STI infections in the USA.

binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced that Jeff Luber, Chief Executive Officer of binx health, will present a company overview presentation at William Blair’s Innovator Series: Life Science Tools and Diagnostics on December 13th, 2022. The presentation will be followed by a Q&A session led by William Blair’s Research team.

binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, today announced a strategic agreement with Afaxys Group Services LLC to expand access to sexual health and wellness testing nationally through their Group Purchasing Organization (GPO). Under the agreement, binx will offer its FDA-cleared, CLIA-waived point-of-care test for chlamydia (CT) and gonorrhea (NG) and its at-home digital health platform to thousands of clinics across the United States, under a preferred pricing model with joint marketing outreach among Afaxys and binx.

binx health, a healthcare technology and women’s health company focused on making routine testing broadly accessible and convenient, announced today the launch of its instrument placement program for CLIA-waived facilities. This program eliminates all upfront instrument costs, enabling access to rapid testing and helping pave the way to better health outcomes. CT and NG are two of the most tested for sexually transmitted infections1 (STIs). With millions of CT/NG tests processed at central laboratories annually2, and 230,000 CLIA-waived sites across the United States3, the binx io can be a catalyst for transforming how and where STI’s are diagnosed and treated. The company has begun accepting pre-orders under its “early access” program for Q1 deliveries.

In a first of its kind partnership, the Alabama Department of Public Health (ADPH) and binx health, a healthcare technology and diagnostics company, enable access to routine remote sample collection for sexually transmitted infections (STIs) and subsequent treatment for Alabama residents.

Ernst & Young LLP (EY US) today announced that Jeffrey Luber, Chief Executive Officer of binx health, was named an Entrepreneur Of The Year® 2022 New England Award winner. Entrepreneur Of The Year® is one of the preeminent competitive business awards for entrepreneurs and leaders of high-growth companies who think big to succeed. An independent panel of judges selected Jeffrey Luber based on his entrepreneurial spirit, purpose, growth, and impact, among other core contributions and attributes.

Ernst & Young LLP (EY US) announced that Jeff Luber, Chief Executive Officer of binx health, has been named an Entrepreneur Of The Year® 2022 New England Award finalist. Entrepreneur Of The Year is one of the preeminent competitive business awards for entrepreneurs and leaders of high-growth companies who think big to succeed.

binx health, a healthcare technology and diagnostics company focused on making routine testing convenient, has partnered with student health insurer Wellfleet to broaden access to human papillomavirus (HPV) testing through convenient, at-home sample collection. The companies believe this joint initiative will encourage more Americans to get tested for HPV, in the settings and at the times most convenient for them. The Biden Administration highlighted HPV infections among its key areas of focus in its Cancer Moonshot reignition announcement earlier this year. Through this partnership between binx health and Wellfleet, a Berkshire Hathaway company and one of the nation’s largest student health insurance carriers, universities can offer their communities binx technology solutions and at-home sample collection for high-quality diagnostic testing to broaden access to HPV tests and help prevent its spread.

binx health, a healthcare technology and diagnostics company, announced today the appointment of Jack Crowley as Chief Financial Officer (CFO). Crowley brings deep industry expertise in life sciences and demonstrated results in successful initial and secondary public offerings, capital structure enhancements, analyst collaboration, and investor relations.

binx health, a healthcare technology and diagnostics company is pleased to announce its selection as a finalist in the Medical Design Excellence Awards 2022. The Medical Design Excellence Awards (MDEA) is the premier awards program for the medtech industry with a mission to recognize significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility.

binx health, a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people live, work, study, and shop, announced today the appointment of Todd Bennett as Chief Commercial Officer (CCO). Bennett is an accomplished industry veteran, having held multiple executive leadership roles at several high-growth companies including Luminex, Immucor, Roche and Abbott.

binx health, a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people live, work, study, and shop, announced that the states of North Carolina and Maryland have awarded the company with contracts to provide access to the Company’s FDA emergency-use-authorized, at-home, lower nasal swab COVID-19 sample collection kits for molecular diagnostic processing at binx laboratory partners as well as access to saliva collection for those that prefer that option. The goals of these programs are to create a consistent supply of tests to support the North Carolina and Maryland testing programs. The Company also announced that Health Canada has issued a Medical Device Establishment License (MDEL) allowing the company to distribute its binx health at-home COVID-19 nasal swab sample collection kit in Canada.

binx health, a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people live, work, study, and shop, announced today that CB Insights ranked binx health among the most promising digital health startups in the world.

binx health, through an expanded agreement with student health insurer Wellfleet, will provide college students nationwide access to sexually transmitted infection (STI) testing. The agreement will enable students from all colleges and universities offering student health insurance from Wellfleet, a Berkshire Hathaway company and one of the nation’s largest student health insurance carriers, access to testing through the binx everywhere at-home and in-dorm digital platform from binx health, a healthcare technology and diagnostics company that brings convenient care to the locations where people live, work, study, and shop.